Literature DB >> 21824654

Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma.

Stephanie J Carter, Steven H Bernstein, Jonathan W Friedberg, Paul M Barr.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21824654     DOI: 10.1016/j.leukres.2011.07.014

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  8 in total

1.  Increased Risk of Infectious Complications in Older Patients With Indolent Non-Hodgkin Lymphoma Exposed to Bendamustine.

Authors:  Monica Fung; Eric Jacobsen; Arnold Freedman; Daniel Prestes; Dimitrios Farmakiotis; Xiangmei Gu; Paul L Nguyen; Sophia Koo
Journal:  Clin Infect Dis       Date:  2019-01-07       Impact factor: 9.079

2.  Progressive multifocal leukoencephalopathy following treatment with bendamustine and rituximab.

Authors:  Sean Warsch; Peter J Hosein; Michele I Morris; Uygar Teomete; Ronald Benveniste; Jennifer R Chapman; Izidore S Lossos
Journal:  Int J Hematol       Date:  2012-06-09       Impact factor: 2.490

Review 3.  Bendamustine in indolent non-Hodgkin's lymphoma: a practice guide for patient management.

Authors:  Wolfram Brugger; Michele Ghielmini
Journal:  Oncologist       Date:  2013-07-30

4.  A case of Pneumocystis jiroveci pneumonia after bendamustine-based chemotherapy for refractory diffuse large B-cell lymphoma.

Authors:  Jeonghoon Ha; Yunhwa Jung; Yunduk Jung; Sanbin Lee; Yoonseo Lee; Insook Woo
Journal:  Blood Res       Date:  2016-03-25

Review 5.  Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis.

Authors:  Xuqin Jiang; Xiaodong Mei; Di Feng; Xiaojing Wang
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

Review 6.  Bendamustine and pneumocystis pneumonia: A systematic review.

Authors:  Atousa Hakamifard; Masoud Mardani; Mohammad Javad Nasiri; Tahereh Gholipur-Shahraki
Journal:  Health Sci Rep       Date:  2022-04-26

7.  Pneumocystis jiroveci prophylaxis in patients undergoing Bendamustine treatment: the need for a standardized protocol.

Authors:  Tarig Mohammed Abkur; Mamoun Saeed; Saad Zeinalabdin Ahmed; Ryan McArthur; Maeve Leahy; Hilary O'Leary; Denis O'Keeffe
Journal:  Clin Case Rep       Date:  2015-02-09

8.  Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction-based diagnosis in patients receiving bendamustine.

Authors:  Mikhaila L Rice; Jason N Barreto; Carrie A Thompson; Kristin C Mara; Pritish K Tosh; Andrew H Limper
Journal:  Cancer Med       Date:  2021-06-22       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.